Investment Rating - The investment rating for the company is "Accumulate" and maintained [8] Core Views - In H1 2025, the company achieved revenue of 1.312 billion yuan, a year-on-year decrease of 32.12%, while the net profit attributable to the parent company was 117 million yuan, a year-on-year increase of 16.01% [2][6] - The decline in revenue was primarily due to a decrease in biodiesel sales, while the production of natural fatty alcohol, which began trial production in April 2025, contributed 82.24 million yuan in revenue [2][6] - The company is actively responding to the EU's anti-dumping sanctions on biodiesel by accelerating its global layout and extending its industrial chain [2][12] Summary by Sections Financial Performance - In H1 2025, biodiesel revenue was 1.07 billion yuan, down 42.3% year-on-year, with sales volume at 125,000 tons, a decrease of 37.55% [12] - The average selling price of biodiesel was 8,533.6 yuan per ton, down 7.7% year-on-year [12] - The gross margin for H1 2025 was 10.17%, an increase of 3.83 percentage points, mainly due to the high gross margin from the fatty alcohol business [12] - The cash collection ratio was 95.71%, a slight decrease of 3.41 percentage points year-on-year [12] Strategic Initiatives - The company is addressing the EU's anti-dumping tax of 23.4% by adjusting market strategies, expanding into non-EU markets, and extending into downstream bio-based materials [12] - Future growth is expected from new production capacities in Singapore and domestic projects, which are anticipated to enhance profitability [12] Profit Forecast - The projected net profit attributable to the parent company for 2025-2027 is 247 million, 371 million, and 436 million yuan, representing year-on-year growth of 66%, 50%, and 17% respectively [12]

Group 1 - The China Securities Regulatory Commission approved Suzhou Fengbei Biotechnology Co., Ltd.'s initial public offering registration, with plans to raise 1 billion yuan [1] - Fengbei Biotechnology aims to list on the Shanghai Stock Exchange, with Guotai Junan Securities as its sponsor [1] Group 2 - Fengbei Biotechnology is a high-tech enterprise in the field of waste resource utilization, primarily producing resource-based products from waste oils [4] - The company has developed a waste resource recycling industry chain, focusing on "waste oils - biofuels (biodiesel) - bio-based materials" [4] - As of the end of 2024, the company's biodiesel production capacity is 105,000 tons, ranking sixth in China's biodiesel industry [4] - According to USDA statistics, China's biodiesel production is projected to be approximately 1.71 million tons in 2024, with Fengbei's biodiesel production at 80,100 tons, giving it a market share of about 4.68% based on production volume [4]

Group 1 - The core viewpoint of the news is that Zhuoyue New Energy has seen a significant increase in its stock price, rising by 6.08% to reach 50.92 yuan per share, with a total market capitalization of 6.11 billion yuan [1] - Zhuoyue New Energy Co., Ltd. is located in Longyan City, Fujian Province, and was established on November 1, 2001. The company specializes in producing biodiesel and its deep-processed products using waste oil as raw material through modern production technologies [1] - The trading volume for Zhuoyue New Energy was 16.62 million yuan, with a turnover rate of 0.28% as of the report [1] Group 2 - According to data from the top ten heavy positions of funds, one fund under Jianxin Fund has a significant holding in Zhuoyue New Energy. Jianxin New Materials Select Stock Fund A (018194) increased its holdings by 3,057 shares in the second quarter, bringing its total to 41,100 shares, which accounts for 3.19% of the fund's net value [2] - Jianxin New Materials Select Stock Fund A was established on August 22, 2023, with a latest scale of 38.31 million yuan. The fund has achieved a return of 40.77% this year, ranking 606 out of 4,222 in its category [2] - The fund manager, Li Mengyuan, has been in charge for 1 year and 297 days, with the fund's total asset scale at 61.92 million yuan. During her tenure, the best fund return was 74.35%, while the worst was 72.9% [2]

Core Viewpoint - Indonesia urges the European Union to immediately lift anti-subsidy duties on imported biodiesel, following support from the World Trade Organization (WTO) for Indonesia's claims against the EU's tariffs [1] Group 1: Trade Dispute - Indonesia, as the world's largest palm oil exporter, filed a complaint in 2023 against the EU's tariffs, claiming they violate WTO rules [1] - The EU has imposed tariffs ranging from 8% to 18% on Indonesian biodiesel since 2019, citing that Indonesian producers benefit from government subsidies and below-market prices for raw materials [1] - The WTO expert panel determined that Indonesia's export duties on palm oil should not be classified as subsidies, which was welcomed by the Indonesian Palm Oil Association (GAPKI) [1] Group 2: Trade Agreement Progress - The ongoing dispute is part of a series of tensions between the EU and Indonesia regarding biodiesel tariffs and issues related to palm oil and deforestation [1] - Following a political agreement reached in July, both parties are nearing the signing of a free trade agreement [1] Group 3: Export Data - Indonesia's biodiesel exports based on palm oil are projected to be 27 million liters in 2024, a significant decline from 1.32 billion liters in 2019 [1]

Core Insights - The price of Sustainable Aviation Fuel (SAF) has increased by over 15% year-on-year, with the current price at $2600.54 per ton, reflecting a week-on-week increase of 15.06% [1][2] - The price of Hydrotreated Vegetable Oil (HVO) has decreased slightly by 0.24% week-on-week, currently priced at 2320.25 yuan per ton [1][2] - European UCOME prices have risen by 0.63% week-on-week, now at €1295.06 per ton, while Chinese UCOME prices remain stable at $1170.20 per ton [1][2] - Southeast Asian biodiesel prices have increased by 0.44% week-on-week, currently at $1176.25 per ton [1][2] Industry Dynamics - SAF prices have seen a significant increase, with European HVO prices also rising slightly. The current FOB FARAG price for SAF is $2574.25 per ton, indicating a positive trading atmosphere among Central European SAF traders [3] - Ireland has announced a Sustainable Aviation Fuel Development Roadmap, aiming for a mandatory SAF supply ratio of 2% by 2025, 6% by 2030, and 20% by 2035 [3] - Malaysia plans to start producing SAF by the end of 2025 and is revising its National Biofuel Policy to include SAF as a strategic component [3][4] Investment Recommendations - The global biodiesel market is expected to see growth due to the demand for bio-jet fuel and bio-marine fuel, alongside the cancellation of export VAT refunds for raw materials [4] - Companies with significant biodiesel or raw material production capacity, such as Zhuoyue New Energy, Jiaao Environmental Protection, Shanggou Environmental Energy, Haineng Science and Technology, and Langkun Environment, are recommended for attention [4]

Core Viewpoint - The company,卓越新能, has received approval from the Shanghai Stock Exchange for its simplified procedure to issue shares to specific investors, pending final registration approval from the China Securities Regulatory Commission (CSRC) [1] Group 1: Share Issuance Details - The company plans to issue 7,190,795 shares at a price of 41.72 yuan per share, aiming to raise a total of 300 million yuan, which will be used for a project to produce 100,000 tons of hydrocarbon biodiesel annually [1] - The issuance is targeted at specific investors, including various fund management companies and private investment funds, all subscribing in cash [2] Group 2: Investor Relations - The investors involved in this issuance do not have any prior relationship with the company, ensuring that the transaction does not constitute a related party transaction [3] - The lead underwriter for this share issuance is Huafu Securities, with representatives Zhou Jianwu and Hong Bin overseeing the process [3] Group 3: Company Control - The actual controllers of卓越新能 are identified as Ye Huodong, Luo Chunmei, and Ye Shaojing, with nationalities from China and Vanuatu [3]

Core Viewpoint - The company,卓越新能, reported a decrease in revenue but an increase in net profit for the first half of 2025, indicating effective cost management and strategic market positioning [2]. Group 1: Financial Performance - The company achieved a sales volume of 150,700 tons of biodiesel and bio-based materials, with a revenue of 1.312 billion yuan, a year-on-year decrease of 32.12% [2]. - The net profit attributable to shareholders was 117 million yuan, reflecting a year-on-year increase of 16.01% [2]. Group 2: Biodiesel Sector - The company optimized product structure and controlled raw material costs, which helped mitigate market risks and prioritize profitability [3]. - The company is expanding its market presence in Europe and Southeast Asia, establishing deep partnerships with overseas clients [3]. - Ongoing projects include a 100,000-ton hydrocarbon-based biodiesel production line, which is in the pipeline installation phase, and a biodiesel production line in Thailand that has completed land leasing and is in the design phase [3]. Group 3: Bio-based Materials Sector - A 50,000-ton natural fatty alcohol production facility commenced operations in April, meeting high standards for surfactant raw materials [4]. - The company utilizes advanced technology to produce natural fatty alcohol, enhancing the application of biodiesel in bio-based chemicals and achieving domestic substitution [4]. - The company plans to expand production capacity based on operational performance and market demand [4]. - The company announced a fundraising plan to raise 300 million yuan for a new 100,000-ton hydrocarbon-based biodiesel project, with a total investment of 380 million yuan [4].

Group 1 - The Chinese government aims to establish a comprehensive national carbon market by 2030, focusing on quota control and a combination of free and paid allocation methods [1] - The average price of carbon emission allowances in China has increased from 46.60 yuan per ton in 2021 to 91.82 yuan per ton in 2024, nearly doubling [1] - In 2024, the total transaction volume of carbon emission allowances reached 189 million tons, with a total transaction value of 18.114 billion yuan, marking a new annual high for the carbon market [1] Group 2 - The strengthening of the carbon market in China presents significant opportunities for companies involved in carbon asset management, low-carbon technologies, high-emission industry transformation, and financial services [2] - Companies like Zhuoyue New Energy, a leader in the biodiesel industry, are expected to grow under the carbon reduction context [3] - Yingke Recycling, with its full industry chain advantage in "plastic recycling - regeneration - utilization," is recognized as a rare asset with global market presence and strong ESG attributes [3]

Core Viewpoint - Fengbei Biotechnology Co., Ltd. has successfully submitted its IPO registration on the Shanghai Stock Exchange, focusing on the comprehensive utilization of waste resources, particularly converting waste oils into biodiesel and bio-based materials, but faces challenges including performance decline due to EU anti-dumping policies and weak R&D investment [1][10][24]. Group 1: Company Overview - Fengbei Biotechnology is a high-tech enterprise in the waste resource utilization sector, primarily producing biodiesel and bio-based materials from waste oils, forming a recycling industry chain [2][5]. - The company was established in July 2014 and transitioned to a joint-stock company in January 2022, with its founder, Ping Yuan, holding 85.40% of the shares [4][5]. Group 2: Financial Performance - For the years 2022 to 2024, Fengbei's operating revenues were 1.709 billion, 1.728 billion, and 1.948 billion yuan, with year-on-year growth rates of 31.89%, 1.12%, and 12.75% respectively [10][11]. - The net profit attributable to the parent company for the same period was 133 million, 130 million, and 124 million yuan, showing a decline of 2.73% and 4.54% in the last two years [10][11]. Group 3: Market Challenges - The company has faced significant challenges due to the EU's anti-dumping investigations, which have led to a sharp decline in sales in the EU market, affecting overall profitability [15][18]. - Sales to the EU dropped from 3.30 billion yuan in 2021 to 505 million yuan in the first half of 2024, indicating a substantial market shift [15][18]. Group 4: R&D and Competitive Position - Fengbei's R&D expenses as a percentage of operating income were 3.00%, 3.39%, and 2.75% from 2022 to 2024, which is below the industry average [21][22]. - The company claims its competitive advantage lies in basic research, material development, and application development, but it risks falling behind competitors if R&D investment does not increase [24]. Group 5: Financial Health - As of the end of 2024, Fengbei's cash reserves were 167 million yuan, while short-term borrowings amounted to 173 million yuan, indicating potential liquidity issues [24].

Core Viewpoint - Fengbei Bio is a high-tech enterprise in the field of waste resource utilization, focusing on converting waste oils into biodiesel and bio-based materials, but faces challenges such as declining performance due to EU anti-dumping policies and insufficient R&D investment [2][14][20]. Company Overview - Fengbei Bio was established in July 2014 and transitioned to a joint-stock company in January 2022, with a registered capital of 5 million yuan [4]. - The founder, Ping Yuan, holds 85.40% of the shares, maintaining absolute control over the company [4][5]. - The company has acquired stakes in several related companies to enhance its operational scale and market competitiveness [4][6]. Financial Performance - Revenue for 2022, 2023, and projected 2024 is 1.709 billion yuan, 1.728 billion yuan, and 1.948 billion yuan, respectively, showing a growth of 31.89%, 1.12%, and 12.75% [9][10]. - Net profit for the same years is 133.34 million yuan, 129.71 million yuan, and 123.82 million yuan, indicating a decline of 2.73% and 4.54% in 2023 and 2024 [9][10]. - The company has distributed significant cash dividends of 15 million yuan and 16.14 million yuan in 2022 and 2023, respectively, totaling 31.14 million yuan [7]. Market Challenges - The company faces a significant decline in sales to the EU due to anti-dumping investigations, with sales figures dropping from 3.30 billion yuan in 2021 to 505.12 million yuan in the first half of 2024 [16][18]. - The EU accounts for 34.65% of global biodiesel consumption, making it a critical market for Fengbei Bio [12]. R&D and Competitive Position - R&D expenses as a percentage of revenue have decreased from 3.39% in 2023 to 2.75% in 2024, which is below the industry average [20][21]. - The company’s biodiesel production capacity is 105,000 tons, significantly lower than competitors like Zhuoyue New Energy and Jiaao Environmental Protection [22]. Future Outlook - The company is shifting its sales focus to emerging markets outside the EU, such as Switzerland and Singapore, in response to changing policies [15]. - The company’s financial health is concerning, with cash reserves of 167 million yuan against short-term borrowings of 173 million yuan, indicating potential liquidity issues [24][25].